Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people

[1]  C. Richart,et al.  Upregulation of Lipocalin 2 in Adipose Tissues of Severely Obese Women: Positive Relationship With Proinflammatory Cytokines , 2011, Obesity.

[2]  E. Rosen,et al.  A minor role for lipocalin 2 in high-fat diet-induced glucose intolerance. , 2011, American journal of physiology. Endocrinology and metabolism.

[3]  D. Mashek,et al.  Lipocalin 2 is a selective modulator of peroxisome proliferator‐activated receptor‐γ activation and function in lipid homeostasis and energy expenditure , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  F. Reis,et al.  Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties , 2011, Cardiovascular diabetology.

[5]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[6]  C. Ling,et al.  Elevated serum chemokine CXC ligand 5 levels are associated with hypercholesterolemia but not a worsening of insulin resistance in Chinese people. , 2010, The Journal of clinical endocrinology and metabolism.

[7]  S. Kaser,et al.  Adipokine update – neue Moleküle, neue Funktionen , 2010, Wiener Medizinische Wochenschrift.

[8]  M. Sjöström,et al.  The Human Visceral Fat Depot Has a Unique Inflammatory Profile , 2010, Obesity.

[9]  E. Çakal,et al.  Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome. , 2010, Journal of endocrinological investigation.

[10]  T. Mak,et al.  Lipocalin-2 Deficiency Attenuates Insulin Resistance Associated With Aging and Obesity , 2010, Diabetes.

[11]  E. Renard,et al.  CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance. , 2009, Cell metabolism.

[12]  O. Franco,et al.  Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese. , 2008, The Journal of clinical endocrinology and metabolism.

[13]  Philip A Kern,et al.  Adipocytokines and the metabolic complications of obesity. , 2008, The Journal of clinical endocrinology and metabolism.

[14]  D. Bernlohr,et al.  The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. , 2008, Molecular endocrinology.

[15]  N. Houstis,et al.  The Adipokine Lipocalin 2 Is Regulated by Obesity and Promotes Insulin Resistance , 2007, Diabetes.

[16]  Paul M Ridker,et al.  C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. , 2006, Journal of the American College of Cardiology.

[17]  S. Haffner,et al.  The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. , 2006, The American journal of cardiology.

[18]  Shizuo Akira,et al.  Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron , 2004, Nature.

[19]  R. Cooksey,et al.  Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. , 2004, Endocrinology.

[20]  J. Fernández-Real,et al.  Insulin resistance and chronic cardiovascular inflammatory syndrome. , 2003, Endocrine reviews.

[21]  H. Erdjument-Bromage,et al.  An iron delivery pathway mediated by a lipocalin. , 2002, Molecular cell.

[22]  K. Kristiansen,et al.  A Proteomic Approach for Identification of Secreted Proteins during the Differentiation of 3T3-L1 Preadipocytes to Adipocytes* , 2002, Molecular & Cellular Proteomics.

[23]  Bei-fan Zhou.  Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. , 2002, Biomedical and environmental sciences : BES.

[24]  J. G. Teodoro,et al.  Induction of Apoptosis by a Secreted Lipocalin That is Transcriptionally Regulated by IL-3 Deprivation , 2001, Science.

[25]  Gould Mn,et al.  Overexpression of neu-related lipocalin (NRL) in neu-initiated but not ras or chemically initiated rat mammary carcinomas. , 1995 .

[26]  H. Sengeløv,et al.  Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. , 1994, Blood.

[27]  H. Sengeløv,et al.  Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. , 1993, The Journal of biological chemistry.

[28]  P. Farrell,et al.  Hepatic glucose production and insulin sensitivity and responsiveness in iron-deficient anemic rats. , 1993, The American journal of physiology.

[29]  M. Druckenmiller,et al.  Increased insulin sensitivity in iron-deficient rats. , 1988, The Journal of nutrition.

[30]  Z. Varghese,et al.  Insulin Resistance and Iron Overload , 1983, Annals of clinical biochemistry.

[31]  E. Kraegen,et al.  Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. , 2007, Clinical chemistry.

[32]  M. Gould,et al.  Overexpression of neu-related lipocalin (NRL) in neu-initiated but not ras or chemically initiated rat mammary carcinomas. , 1995, Oncogene.